# Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple Sclerosis

> **NCT05080270** · EARLY_PHASE1 · COMPLETED · sponsor: **FibroBiologics** · enrollment: 5 (actual)

## Conditions studied

- Multiple Sclerosis, Relapsing-Remitting
- Multiple Sclerosis

## Interventions

- **BIOLOGICAL:** Tolerogenic Fibroblasts

## Key facts

- **NCT ID:** NCT05080270
- **Lead sponsor:** FibroBiologics
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-21
- **Primary completion:** 2021-06-08
- **Final completion:** 2021-06-08
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2021-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05080270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05080270, "Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple Sclerosis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05080270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*